Jiing–Chyuan Luo

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Mei‐Jyh Chen et al. · The Lancet · 2012 · 269 citations

Medicine, Internal Medicine, Pharmacology +7

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chih‐Min Chang et al. · The Lancet Infectious Diseases · 2019 · 208 citations

Life Sciences, Microbiology, Pharmacology +17

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Yu-Jen Fang, Chieh‐Chang Chen et al. · The Lancet · 2016 · 202 citations

Medicine, Pharmacology, Pharmacotherapy +7

Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma

Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung et al. · Journal for ImmunoTherapy of Cancer · 2022 · 197 citations · Full text

Life Sciences, Microbiology, Oncology +17

Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation

Shinn‐Jang Hwang, Jiing–Chyuan Luo, Chen‐Wei Chu et al. · Journal of Gastroenterology and Hepatology · 2001 · 186 citations

Medicine, Infectious Diseases, Pathology +16